U.S.-approved mRNA flu shot may soon be in Canada. Here’s what one expert says

The first approval in the U.S. for a messenger RNA-based flu vaccine was signed off on by the U.S. Food and Drug Administration on Wednesday. The new vaccine, mFlusiva, will be available for adults aged 50 and older.